Cambridge
$106k - $129k
full-time
Are you the employer? Manage your company page directly.
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
Associate Scientist, Cell Therapy
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How you will Achieve More with Intellia:
The successful candidate will be responsible for laboratory activities related to the research and development of CRISPR/Cas9 genome edited and mRNA-CAR T cell therapies for oncology and autoimmune disorders. You will work alongside teammates to execute experiments to assess and optimize delivery of cargo to immune cells and test for functionality in vitro and in vivo. Perform in-vitro assays to quantify cargo delivery to T-cells and perform immunoassays (cytotoxicity and cytokine release) to evaluate potency and specificity of engineered T cells. The candidate will support the team by performing in-vivo studies using murine models to evaluate therapeutic efficacy. Collaborative skills will be instrumental to work within a matrixed organization to improve understanding of CAR T cell, mRNA, and LNP biology.
About You:
This position requires a Master’s degree in Biological Sciences, Bioengineering, Medical Biotechnology, or a directly related field and at least two years of laboratory experience in industry. Alternatively, candidates with a Bachelor’s degree plus at least four years of laboratory experience in industry will be considered.
Additionally, the successful candidate will have laboratory experience in these areas:
Meet your future team:
You will be joining the Cell Therapy team within the Research and Early Development organization. The group collaborates closely with many other teams including Delivery Sciences and PharmTox teams providing cross-functional exposure and development opportunities.
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.
The base salary for this position is expected to range between $106,200.00 - $129,800.00 USD per year.The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.
Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion.
For more information about Intellia’s benefits, please click here.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.
Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology’s attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic.
View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/ .
Get matched with similar opportunities at top startups
This role is hosted on Intellia Therapeutics, Inc.'s careers site.
Join our talent pool first to get notified about similar roles that match your profile.